Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Scott Weingart. EMCrit RACC Podcast 217 – The Ultimate “Ultimate” BVM. EMCrit Blog. Published on February 5, 2018. Available at [https://emcrit.org/racc/ultimate-bvm/ ]

Buscar en contenido

Contenido:

sábado, 3 de febrero de 2018

IV Lidocaine for pain

Mayo Clinic
EMBlog Mayo Clinic - February 2, 2018 - By Daniel Cabrera 
Author: Lucas Oliveira J. e Silva 
"Lidocaine is a local anesthetic agent of the amide type that has been described as containing analgesic, anti-hyperalgesic and anti-inflammatory properties. It has a short half-life (60 to 120 minutes) and its side effects are often predictable. Due to its short half-life, toxicity symptoms at lower doses are generally transient, although its analgesic effect might last more than expected. Lidocaine for pain control, administered by intravenous (IV) injection, has been studied in various settings, including the operating room for management of perioperative pain and outpatient clinics for treatment of neuropathic pain. Its use in the Emergency Department (ED), however, has only recently gained attention after emerging evidence for the management of pain of renal colic patients in the ED..."